SCHEMBL1908612

SCHEMBL1908612

COc1cc(C=O)c2sc(OC)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
ERN1 O75460 3/20 0.39
TRIM24 O15164 1/20 0.39
TYR P14679 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
KDM4E B2RXH2 4/20 0.34
RAB9A P51151 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
MEN1 O00255 3/20 0.34
NPC1 O15118 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 2/20 0.34
NQO2 P16083 1/20 0.34
CYP1A2 P05177 4/20 0.33
CYP2C19 P33261 4/20 0.33
CYP3A4 P08684 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
TSHR P16473 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1908578 0.84 ALDH1A1 (0.34) ALDH1A1KDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL14508482 0.76 CYP2A6 (0.41) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL24994674 0.73 ALDH1A1 (0.41) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL616550 0.73
SCHEMBL21395529 0.69 ERN1 (0.39) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL1908581 0.69 NPC1 (0.35) RAB9ANPC1
SCHEMBL21379479 0.68 ALDH1A1 (0.42) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL22960799 0.67 ERN1 (0.41) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL28910023 0.66 ALDH1A1 (0.44) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL10728453 0.66 ERN1 (0.53) ALDH1A1ERN1TRIM24TYRTRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041041-A1 5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY NOVARTIS AG 2012-02-16 US disclosed
US-8076489-B2 3H-benzothiazol-2-one derivatives, for example, (R)-7-[2-(1,1-dimethyl-2-phenyl-ethylamino)-1-hydroxy-ethyl]-5-hydroxy-3H-benzothiazol-2-one; useful for treating conditions that are prevented or alleviated by activation of the beta 2-adrenoreceptor NOVARTIS AG (CH) 2011-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041041-A1 5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY ADRB2, ADRB1, ADRA2C ALDH1A1 525/4885ERN1 4023/4885TRIM24 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.